Revenues increased to RMB2.04 billion,representing 48.3% year-over-year growth Adjusted net profit reached RMB50.9 million,from an adjusted net loss of RMB17.4 million in the same period of 2023
08-29
Approval of ivonescimab for 2L+ EGFRm NSCL; HARMONi-A is the only phase III study that demonstrates significant benefit across all subgroups for PFS,and is also the only study to achieve the primary e
08-29
SHENZHEN,China,Aug. 28,2024-- UTime Limited (NASDAQ:WTO) ("UTime" or the "Company")has officially announced the signing of a non-disclosure agreement (the "NDA") with Bow
08-29
The initiative provides opportunities forBabilou Family Singapore\'s early childhood educators to share best practices,equipping them with global insights.
08-29
LIMASSOL,Cyprus,Aug. 29,2024--Doo Prime successfully concluded a premier partner event held at the renowned Old Trafford Stadium on Saturday,August 10,2024. As one of the most significant gatherings
08-29
HONG KONG,Aug. 27,2024-- On August 22,AAC Technologies (02018.HK) held its 2024 interim results presentation in Hong Kong,delivering remarkably impressive performance.
08-28
INDIANAPOLIS and PARIS,Aug. 27,2024-- Stamus Networks,a global provider of high-performance network-based threat detection and response (NDR) systems,today announced it has been named a Sample Vendor
08-28
BRADENTON,Fla.,Aug. 27,2024-- BAIYU Holdings,Inc. ("BAIYU" or the "Company") (Nasdaq: BYU),a leading B2B bulk commodity e-commerce platform and supply chain service provider,today
08-28
PISCATAWAY,N.J.,Aug. 27,2024-- Legend Biotech (NASDAQ: LEGN),a subsidiary of GenScript Biotech Corporation (hereinafter referred to as "GenScript"),a global leader in life sciences research
08-28
BEIJING,Aug. 28,2024-- Jenscare Scientific Co.,Ltd. ("Jenscare" or the "Company") (HKEX: 9877),an innovative medical device company dedicated to interventional treatment for struct
08-28
CGTN: How China embraces the world with open arms, boosts development for all
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
©copyright 2009-2020 Singapore Info Map
